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A novel paradigm of keratinocyte (KC) regulation via nicotinic acetylcholine receptors (nAChR) has been discov-
ered in studies of SLURP (secreted mammalian Ly-6/urokinase-type plasminogen activator receptor-related pro-
tein)-1 in Mal de Meleda. We cloned human SLURP-1 and produced recombinant protein and the monoclonal
antibody 336H12-1A3 that visualized native SLURP-1. SLURP-1 ligated the conventional ligand-binding site of KC
nAChR, showing a higher afﬁnity to the [3H]nicotine-, compared with the [3H]epibatidine-sensitive nAChR. SLURP-1
significantly (po0.05) increased the activities of caspases 3 and 8, and the number of terminal deoxynucleotidyl
transferase-mediated dUTP-biotin nick end-labeling-positive cells. The pro-apoptotic activity of SLURP-1 exceeded
that of tumor necrosis factor-a, suggesting the involvement of separate pathways. In a series of real-time PCR and
in-cell western experiments, SLURP-1 significantly (po0.05) upregulated expression of transglutaminase type I
cytokeratin 10, p21, and caspase-3. In the presence of the agonist carbachol, the effects of SLURP-1 on gene
expression were augmented, which is in keeping with the notion that SLURP-1 acts as an allosteric agonist at the
KC nAChR. Thus, the changes in the cell state induced by SLURP-1 could result from nAChR-mediated effects on
the KC gene expression. These results suggest that the biological role of SLURP-1 in the epidermis is to provide
ﬁne tuning of the physiologic regulation of KC functions through the cholinergic pathways.
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The continuous cycle of keratinocyte (KC) birth and death is
a self-sustained process controlled, in part, by locally pro-
duced acetylcholine (ACh) through the signaling pathways
that couple each type of ACh receptors to a particular cell
function. A novel paradigm of the physiologic regulation of
epidermal KC via ACh receptors has been discovered in
studies of SLURP (secreted mammalian Ly-6/urokinase-
type plasminogen activator receptor (uPAR)-related prote-
in)-1 in the autosomal recessive inflammatory and keratotic
palmoplantar skin disorder Mal de Meleda (Fischer et al,
2001; Mastrangeli et al, 2003), which features biochemical
characteristics of the hyperproliferative epithelium (Sybert
et al, 1988). Mutations in the ARS B gene encoding the
polypeptide belonging to the Ly-6/CD59/uPAR/snake toxin
superfamily termed SLURP-1 were found to underlie this
disease. The amino acid composition of SLURP-1 is ho-
mologous to that of the single domain frog cytotoxin and
snake venom neurotoxins, such as a-bungarotoxin (Fischer
et al, 2001). KC secrete SLURP-1 protein, which is detect-
able in plasma and urine. In cultured KC, the ARS B mes-
senger (mRNA) expression is upregulated by high
extracellular Ca2þ in the presence of epidermal growth
factor and downregulated by retinoic acid and interferon-g
(Mastrangeli et al, 2003).
Chimienti et al (2003) demonstrated that SLURP-1 is se-
creted by N-terminal signal cleavage and acts as a mod-
ulator of the a7 nicotinic ACh receptor (nAChR). These
authors examined ACh-elicited macroscopic current re-
sponses in control and SLURP-1-treated Xenopus oocytes
expressing recombinant human a7 nAChR. SLURP-1 en-
hanced the amplitude of the ACh-evoked macroscopic cur-
rents in a concentration-dependent manner. It was
concluded that SLURP-1 modulates nAChR function in
the presence of its natural ligand, ACh, in a manner con-
sistent with an allosteric mode of action. The physiological
role of SLURP-1 remained to be identified.
The nAChR are classic representatives of the superfamily
of ligand-gated ion channel proteins, or ionotropic recep-
tors, and they mediate the influx of Naþ and Ca2þ and the
efflux of Kþ (Steinbach, 1990). Myocytes express a1, b1, g,
d, and e subunits. In other cells, 12 nAChR subunit genes
encoding a pentameric protein have been identified and
designated a2–a10 and b2–b4, and each subunit has four
putative transmembrane-spanning domains and a similar
topological structure. Each of a7, a8, and a9 subunits is
capable of forming functional homomeric nAChR channels.
The heteromeric channels can be composed of a2, a3, a4,
a5, a6, b2, b3, and b4 subunits, e.g., a3b2(b4)  a5, and a9
subunit can form a heteromeric channel with a10 (Elgoyhen
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et al, 2001). Human epidermal KC express the a3, a5, a7,
a9, a10, b1, b2, and b4 subunits of the nAChR (Grando et al,
1995a, 1996; Nguyen et al, 2000a, b; Sgard et al, 2002;
Kurzen et al, 2004).
Elucidation of the cholinergic signaling pathways medi-
ating SLURP actions on KC has a potential to provide novel
mechanistic insights into the physiologic processes driving
KC through consecutive steps of their development in the
epidermis, to lead to a better understanding of skin diseas-
es, and to open new avenues for the treatment of skin
diseases. Therefore, in this study, we investigated the
mechanism of receptor binding and the biological effects of
recombinant SLURP-1 protein (rSLURP-1). The results ob-
tained indicate that SLURP-1 regulates KC proliferation,
apoptosis, and differentiation, and may be involved in the
regulation of cutaneous inflammation. These novel activities
of SLURP-1 warrant further investigation as additional study
of the activities of SLURP-1 will be needed in order to fully
elucidate its effects on KC.
Results
Competitive binding of rSLURP-1 to KC To investigate a
possibility that SLURP-1 can competitively bind to the
nAChR expressed on the plasma membrane of KC, we
performed the radioligand binding inhibition experiments
using the nicotinic radioligands [3H]nicotine and [3H]epi-
batidine, and KC monolayers in 24 well plates. rSLURP-1
competed with both nicotinic radioligands used. rSLURP-1
showed a higher affinity to the [3H]nicotine- (Fig 1A) than
[3H]epibatidine- (Fig 1B) labeled binding sites, with EC50
values of 28 nM and 2.2 mM, respectively. These results
clearly demonstrated the presence in KC of the high-affinity
binding sites for SLURP-1.
Endpoint effects of the KC exposure to rSLURP-1 The
biological effects of SLURP-1 were tested in  80% con-
fluence, second passage foreskin KC exposed for 48 h to 1
mg per mL of rSLURP-1. After incubation, the total cell
number was calculated in a hemocytometer, and a fraction
of trypan blue dye (TBD)þ cells was determined. rSLURP-1
decreased the total cell number to 67%  11% (po0.05)
and increased numbers of terminal deoxynucleotidyl trans-
ferase-mediated dUTP-biotin nick end-labeling (TUNEL)þ
cells to 126%  10% (po0.05), compared with the values
determined in control cultures and taken as 100%. The
fraction of TBDþ cells did not statistically differ from con-
trol (103%  17%; p40.05). As rSLURP-1 protein did not
increase the number of TBDþ cells, it was not toxic to the
cells. A decrease in cell numbers, therefore, could result
from a switch in the cell cycle progression from the prolif-
eration to the terminal differentiation and/or programmed
cell death mode.
Stimulation of pro-apoptotic enzymes by rSLURP-1 in
KC Following incubation with rSLURP-1, a portion of KC
was used in the caspase 3 and caspase 8 assays. To induce
programmed cell death, some monolayers were incubated
for 3 h with 10 ng per mL tumor necrosis factor (TNF-a)
(Diker-Cohen et al, 2003). rSLURP-1 exhibited a pro-apo-
ptotic effect by significantly (po0.05) increasing the activ-
ities of caspases 3 and 8 (Fig 2). The pro-apoptotic activity
of rSLURP-1 slightly exceeded that of TNF-a, suggesting
involvement of separate cell death signaling pathways. This
supposition was tested in cultures exposed to a combina-
tion of both agents. As expected, simultaneous stimulation
of KC with rSLURP-1 and TNF-a produced an additive
effect on the activities of both pro-apoptotic enzymes
caspase 3 and 8 (Fig 2).
Alterations in KC gene expression induced by rSLURP-
1 In a series of the real-time PCR and in-cell western ex-
periments, we investigated changes in the relative ratios of
the KC gene expression after 24 h incubation with 1 mg per
mL of rSLURP-1 vs non-treated controls. rSLURP-1 signif-
icantly (po0.05) upregulated expression of cell differentia-
tion markers transglutaminase type I and cytokeratin 10,
the inhibitor of the cell-cycle progression p21, and the
Figure 1
Competitive binding of recombinant secreted mammalian Ly-6/
urokinase-type plasminogen activator receptor-related protein-1
(rSLURP-1) with [3H]nicotine (A) and [3H]epibatidine (B). The num-
bers on the ordinate indicate the -Log molarity of the rSLURP-1 solution
used in the radioligand binding inhibition assays with the monolayers of
human neonatal foreskin keratinocyte, as described in the Materials
and Methods section.
Figure2
Effects of recombinant secreted mammalian Ly-6/urokinase-type
plasminogen activator receptor-related protein-1 (rSLURP) on
enzymatic activities of caspases 3 and 8. Activities of caspase 3
and 8 in keratinocytes incubated with rSLURP-1 were measured using
the fluorometric assay kit as detailed in Materials and Methods. All
experimental values significantly (po0.05) differ from the spontaneous
caspase 3 and 8 activities, taken as controls. RFU, relative fluores-
cence units.
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executioner caspase-3 (Fig 3). In the presence of the ago-
nist carbachol, 1 mM, the effects of rSLURP-1 on gene ex-
pression were augmented, which is in keeping with the
notion that SLURP-1 acts as an allosteric agonist at the KC
nicotinic ACh receptor (Chimienti et al, 2003). Thus, chang-
es in the cell state induced by rSLURP-1 could result from
nAChR-mediated effects on the gene expression influenc-
ing KC growth, differentiation, and programmed cell death.
Discussion
In this study, we demonstrated the biological effects of the
novel epidermal peptidergic cytotransmitter SLURP-1 act-
ing upon the nAChR expressed on the plasma membrane of
human epidermal KC.
Using mouse monoclonal antibody, we visualized
SLURP-1 in the suprabasal compartment of the human ep-
idermis, predominantly in the upper prickle- and granular-
cell layers (Fig. 4). This is in keeping with early reports that
the SLURP-1 positive cells are detectable within the sup-
rabasal layers of the squamous stratified epithelium lining
human skin, mucosa of exoteric, vagina, and gingiva, as
well as in the esophageal epithelium, and that SLURP-1
expression is associated with the mid-to-late differentiation
stages of KC (Mastrangeli et al, 2003). In cell cultures, the
anti-SLURP-1 antibody produced a characteristic perinu-
clear cytoplasmic staining (Fig. 4).
We demonstrated that rSLURP-1 displaces the well-
studied nicotinic ligands nicotine and epibatidine from the
KC nAChR. As nicotine can ligate both the ‘‘ganglionic’’ (i.e.,
a3-made) and the ‘‘central’’ (i.e., a7-made) nAChR, whereas
epibatidine is selective for the ganglionic nAChR subtypes
(Gerzanich et al, 1995; Lindstrom et al, 1995; Cauley et al,
1996; Zhao et al, 2003), the results obtained from these
experiments indicate that rSLURP-1 preferentially binds to
the a7 nAChR. Chimienti et al (2003) proposed that SLURP-
1 is a positive allosteric effector of a7 nAChR based on its
known homology to the a7 antagonist a-bungarotoxin and
results showing potentiation of the macroscopic current re-
sponses to ACh in SLURP-1-treated Xenopus oocytes
expressing recombinant human a7 nAChR. Indeed, an in-
creased ACh sensitivity and increased apparent cooper-
ativity are hallmarks of allosteric effectors (Changeux and
Edelstein, 2001). But other explanations of these results are
also possible. For instance, a-bungarotoxin can block both
a7- and a9-mediated ACh currents (Glowatzki and Fuchs,
2000). Furthermore, in addition to a7 and a9, human KC
also express several a3-containing subtypes of nAChR that
bind snake toxins of the bungarotoxin family (Conti-Tron-
coni et al, 1994). Thus, in addition to acting as an allosteric
ligand of a7, SLURP-1 may exhibit biologic effects on KC
because of conventional binding to this and/or some other
nAChR subtypes.
Binding to nAChR can allow SLURP-1 to modify ACh
signaling in KC. The universal promoter-like action of ACh,
mediated by activation of the nAChR types coupled to
growth-promotion, e.g., a3 (Arredondo et al, 2005), is bal-
anced by simultaneous activation of the growth controlling
nAChR types, e.g., a7 (Arredondo et al, 2002), as both
groups of nAChR are concomitantly expressed on the cell
membrane of a KC (Kurzen et al, 2004). The final cellular
response, mitosis, apoptosis, quiescence, or terminal dif-
ferentiation, is determined by the delicate balance between
the growth promoting and inhibiting signals of ACh as well
as other locally released cytokines and growth factors.
Thus, SLURP-1 can alter this physiologic equilibrium by
selectively activating (or inhibiting) specific subtypes of KC
nAChR.
Binding of rSLURP-1 to KC nAChR apparently activated
the process of cell death distinct from oncosis, which is
associated with cell membrane disruption and TBD posit-
ivity (Majno and Joris, 1995; Trump et al, 1997). By both
real-time PCR and in-cell western analysis, rSLURP-1 dra-
matically altered the expression of the KC genes encoding
markers for the status of cells. It has been postulated earlier
that dysfunction of SLURP genes might lead to the skin
disorders characterized by KC hyperproliferation (Mastran-
geli et al, 2003). Based on its differential expression within
the epidermis and results of the gene expression experi-
ments, we propose that SLURP-1 also plays an important
role in the physiologic regulation of the unfolding of terminal
differentiation and programmed cell death.
It has been postulated that SLURP-1 can control TNF-a
release by dermal macrophages and KC by activating the
a7 nAChR expressed in these cells, thus reducing inflam-
mation (Chimienti et al, 2003). We have demonstrated that
both rSLURP-1 and TNF-a produce pro-apoptotic effects
on KC. Although KC synthesize and release TNF-a (Kock
et al, 1990), it is unlikely that rSLURP-1 stimulated
apoptosis by stimulating TNF-a release, because the ef-
fects of these two molecules were additive, which suggests
that each compound activated a distinct pathway.
In conclusion, these results demonstrate biochemical
and phenotypic alterations of human KC induced by the
novel autocrine and paracrine peptide mediator of the
Figure 3
Alterations in keratinocyte (KC) gene expression induced by re-
combinant secreted mammalian Ly-6/urokinase-type plasminogen
activator receptor-related protein-1 (rSLURP-1). KC were incubated
for 24 h in KC growth medium with 0.09 mM Ca2þ without any ad-
ditions (control) or in the presence of 1 mg per mL of rSLURP-1 with or
without the agonist carbachol, 1 mM. The alterations in the gene ex-
pression are presented relative to the rates of expression of corre-
sponding genes in control samples, taken as 1. All changes significantly
(po0.05) differ from control. (A) Real-time PCR analysis. (B) In-cell
western analysis.
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cholinergic signaling found in the epidermis. As evident from
results published in the literature and obtained in this study,
SLURP-1 is an efficient, but previously unknown, ligand of
KC nAChR. The important role for SLURP-1 in KC biology is
suggested by dramatic changes in the morphology of the
epidermis in Mal de Meleda—the skin disease associated
with abnormalities of this molecule. Changes in the status of
the cell induced by rSLURP-1 could result from nAChR-
mediated effects on gene expression influencing cell
growth, differentiation, and programmed cell death. As the
SLURP-1 gene expression is Ca2þ -dependent, and is con-
trolled by cytokines, growth factors, and retinoids (Mast-
rangeli et al, 2003), elucidation of the mechanisms of
pharmacologic action of SLURP-1 on KC via nAChR should
unveil a novel biological mechanism providing for a fine
tuning of the physiologic regulation of KC through the ACh
signaling axis.
Materials and Methods
Cloning of human SLURP-1 and production of rSLURP-1 Total
RNA from human normal skin complementary DNA (cDNA) (In-
vitrogen, Carlsbad, California) was used to obtain the PCR product
of 508 bp for SLURP-1 (GeneBank accession #AY579079). Human
SLURP-1 was amplified using the gene-specific forward (50-
CTCTCATCACTTCTGAGCAC-30) and reverse (50-GCGTGGGGTATGGAAGG-30)
primers, respectively. The cDNA was inserted into the pET SUMO
vector (Invitrogen) followed by transformation into competent Es-
cherichia coli cells (Invitrogen) for production of the rSLURP-1 that
was purified using the His tag Pro-Bond columns (Bio-Rad, Her-
cules, California) from the bacterial cultures overexpressing
rSLURP-1 (Fig 4A). The N-terminal 6-His tag was then removed
employing SUMO Protease (Invitrogen) that cleaves the N-terminal
peptide containing the 6xHis tag and SUMO protein.
Production of anti-SLURP-1 mouse monoclonal antibody A
synthetic peptide analogue of SLURP-1 (Ac-5-17, S6-S15) was
synthesized by conventional Fmoc-solid phase peptide synthesis;
the crude peptide was partially purified by precipitation and semi-
preparative C18 reverse phase high-performance liquid chroma-
tography (HPLC) prior to formation of the intrachain disulfide bond.
The peptide was cyclized by air oxidation at high dilution to facil-
itate the formation of intrachain disulfide bonds rather than inter-
chain polymerization. The crude cyclized peptide was purified to
greater than 98% purity by preparative C18 reverse phase HPLC,
and then conjugated onto keyhole limpet hemocyanin (KLH) carrier
protein for immunization of mice. A group of six mice was immu-
nized by intraperitoneal injection of an emulsion of the peptide–
KLH conjugate with Freund’s complete adjuvant (first immuniza-
tion) or Freund’s incomplete adjuvant (three booster injections).
The development of antibody recognizing the SLURP-1 was tested
by ELISA, western blot, and cell and tissue staining. Anti-SLURP-1
monoclonal antibodies were developed by fusing with SP 2/0–Ag
14 myeloma cells the splenocytes obtained from a mouse making
antibodies recognizing the synthetic peptide immunogen, rSLURP-
1, and native SLURP-1. Hybridomas were selected using hypox-
anthine, aminopterin, thymidine (HAT) culture medium, and the vi-
able hybridomas were screened for the production of mouse
immunoglobulin (IgG) that bound to the immunogen peptide, to
rSLURP-1, and to native SLURP-1. A number of positive wells were
identified and each was cloned. Clones were tested for production
of monoclonal anti-SLURP-1 antibody. One clone 336H12-1A3
was identified that recognized the immunogen peptide, rSLURP-1
and native SLURP-1. This clone was expanded, and culture supe-
rnatant obtained from clone 336H12-1A3 was used in the exper-
iments reported herein. The antibody was used to visualize both
rSLURP-1 in a western blot (Fig 4B) and the native SLURP-1 pro-
tein in the KC comprising the upper epidermal compartment of
cryostat sections of normal human foreskins (Fig 4C) or grown in
culture (Fig 4D).
Western blotting analysis or rSLURP-1 rSLURP-1 was dis-
solved in a sample buffer, separated via 4%–10% sodium dodecyl
sulfate, and electroblotted onto a 0.2 mm nitrocellulose membrane
(Bio-Rad, Hercules, California), as detailed elsewhere (Arredondo
et al, 2005). The membranes were developed using the ECLþPlus
chemiluminescent detection system (Amersham Pharmacia Bio-
tech, Inc., Piscataway, New Jersey) and scanned with Storm/Flu-
orImager (Molecular Dynamics, Mountain View, California).
Indirect immunoﬂuorescence KC staining produced by anti-
SLURP-1 monoclonal antibody was characterized in the indirect
immunofluorescence experiments performed as detailed else-
where (Grando et al, 1995b) with minor modifications. Briefly, 4–8
mm sections of freshly frozen normal human skin or coverslips
containing KC monolayers were air dried for 15 min, and incubated
overnight at 41C with anti-SLURP-1 monoclonal antibody diluted
1:200 in phosphate-buffered saline (PBS). After washing, the spec-
imens were exposed for 1 h at room temperature to the secondary,
fluorescein-isothiocyanate conjugated rabbit anti-mouse IgG anti-
body.
Figure4
Production of recombinant secreted mammalian Ly-6/urokinase-
type plasminogen activator receptor-related protein-1 (rSLURP-1)
and anti-SLURP-1 monoclonal antibody. (A) Visualization of affinity
purified rSLURP-1 at  22 kDa in 10% sodium dodecylsulfate-polya-
crylamide gel electrophoresis. The molecular weight markers are 135,
96, 51, 37, 20, and 7 from top to bottom. (B) Visualization of affinity
purified rSLURP-1 at  22 kDa in immunoblot with the mouse mono-
clonal antibody 336H12-1A3. The molecular weight markers are 103,
81, 61, and 26 from top to bottom. (C) Localization of keratinocyte (KC)
SLURP-1 in a cryostat section of human neonatal foreskin using anti-
SLURP-1 mouse monoclonal antibody. Anti-SLURP-1 monoclonal an-
tibody stained predominantly granular cells, and upper rows of prickle
KC. Scale bar¼20 mm. (D) Localization of SLURP-1 in the second
passage human foreskin KC incubated in KC growth medium at 1.2
mM Ca2þ . Anti-SLURP-1 monoclonal antibody produced homogenous
cytoplasmic staining and accumulated at the perinuclear area. Scale
bar¼20 mm.
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Radioligand binding inhibition assay Binding of rSLURP-1 to
KC nAChR was investigated in radioligand binding inhibition ex-
periments. The KC were seeded into 24-well culture plates (Becton
Dickinson, Franklin Lakes, New Jersey) at a density of 1  105 cells
per well, and incubated overnight in a 5% CO2 incubator at 371C to
allow the cells to settle and attach to the dish bottom. All exper-
iments were performed in a 200 mL final volume as detailed else-
where (Grando, 2003). Briefly, triplicate monolayers were incubated
for 1 h at 41C in the presence of a saturating concentration of either
radioligand (—)[N-methyl-3H]nicotine (50 nM; specific activity 84.0
Ci per mmol) or [3H]epibatidine (20 nM; specific activity 54.0 Ci per
mmol; both from Amersham Pharmacia Biotech, Inc.) plus log di-
lutions of rSLURP-1. After incubation, the monolayers were
washed with ice-cold PBS and solubilized with 1% SDS. The ra-
dioactivity was counted in a liquid scintillation counter.
Cell culture experiments Normal human KC were obtained from
neonatal foreskins and grown at 371C and 5% CO2 in Falcon cul-
ture flasks (Corning Glass Works, Corning, New York) in serum-free
KC growth medium (KGM) containing 0.09 mM Ca2þ (Gibco-BRL,
Cambridge, Massachusetts) as detailed elsewhere (Grando et al,
1993). Human material was used in accordance to the Helsinki
Guidelines. All experiments were performed using the second to
fourth passage KC monolayers at  80% confluence grown from
at least three different foreskin donors. Experimental KC were ex-
posed to 1 mg per mL of rSLURP-1, and the control cultures were
left untreated. After incubation, the cells were washed thrice with
prewarmed phosphate-buffered saline, and used for caspase 3
and 8 activity assays, quantitation of numbers of TBD-, and TUNEL
(i.e., the terminal deoxynucleotidyl transferase-mediated dUTP-
biotin nick end-labeling)-positive cells, and RNA and protein iso-
lation for the gene expression analysis. Cell number was computed
using a hemocytometer, and the percentage of dead cells was
determined based on TBD positivity. The KC undergoing apoptosis
were visualized using the DeadEnd Fluorometric TUNEL System
purchased from Promega (Madison, Wisconsin). The enzymatic
activities of pro-apoptotic caspase 3 and caspase 8 were deter-
mined using the respective fluorometric assay kits purchased from
Calbiochem (San Diego, California), following the protocols pro-
vided by the manufacturer. Some cells were preincubated with the
pro-apoptotic agent TNF-a (Sigma-Aldrich, Inc., St Louis, Missou-
ri). In real-time PCR and in-cell western experiments, some cells
were exposed to rSLURP-1 in the presence of the cholinergic
agonist carbachol (Sigma-Aldrich).
Real-time PCR Total RNA was extracted from cultured KC at the
end of the exposure experiments using the guanidinium thiocyan-
ate phenol chloroform extraction procedure as described else-
where (Grando et al, 1995b). Primers for the genes encoding
human KC transglutaminase type I, cytokeratin 10, p21, and ca-
spase 3 were designed with the assistance of the Primer Express
software version 2.0 computer program (Applied Biosystems, Fos-
ter City, California), and the Assays-on-Demand provided by
Applied Biosystems. Obtained gene expression values were nor-
malized using the housekeeping gene glyceraldehyde-3-phos-
phate dehydrogenase (GAPDH) to correct minor variations in
mRNA extraction and reverse transcription. All PCR reactions were
performed using an ABI Prism 7500 Sequence Detection System
(Applied Biosystems) and the TaqMan Universal Master Mix rea-
gent (Applied Biosystems) in accordance to the manufacturer’s
protocol. Briefly, 22.5 mL of the diluted cDNA sample produced
from 1 mg of total RNA was added to 25 mL of the PCR master
mix and 2.5 mL 20  Assays-on-Demand Gene Expression Mix.
The data from triplicate samples were analyzed with a sequence
detector software (Applied Biosystems) and expressed as
mean  standard deviation (SD) of mRNA in question relative to
that of GAPDH.
In-cell western The effects of rSLURP-1 on the expression levels
of the KC proteins of interest were determined using the LI-COR’s
in-cell western assay (LI-COR, Lincoln, Nevada). This assay uses
infrared dye-labeled secondary antibodies to directly label proteins
in cells, and quantify total fluorescence from each well. The KC
were seeded in the 96-well plate at a cell density of 5  105 per
well, incubated overnight to allow adherence to the dish bottom,
and used in experiments as described in the Results section. Then,
following the manufacturer’s protocol, the KC were fixed, washed,
permeabilized with Triton solution, incubated with the LI-COR Od-
yssey Blocking Buffer, and exposed for 2 h to a primary antibody to
cytokeratin 10 (COVANCE, Richmond, California), caspase 3
(Oncogene, San Diego, California), transglutaminase type I or
p21 (both from Calbiochem, La Jolla, California), each diluted
1:100 in the LI-COR Odyssey Blocking Buffer. After that, the cells
were washed, stained with a secondary goat anti-rabbit Alexa
Fluor680 (1:10,000 dilution; Molecular Probes, Eugene, Oregon),
and/or goat anti-mouse IRDye 800CW (1:10,000 dilution; Rockland
Immunochemicals, Gilbertsville, Pennsylvania) antibody. The pro-
tein expression was then quantitated using the Odyssey Imaging
System (LI-COR).
Statistical analysis All experiments were performed in triplicates,
or quadruplicates, and the results were expressed as mean  SD.
Statistical significance was determined using Student’s t test. Dif-
ferences were deemed significant if the calculated p value was less
than 0.05.
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